Therapeutic advances of targeting receptor tyrosine kinases in cancer

C Tomuleasa, AB Tigu, R Munteanu… - … and Targeted Therapy, 2024 - nature.com
Receptor tyrosine kinases (RTKs), a category of transmembrane receptors, have gained
significant clinical attention in oncology due to their central role in cancer pathogenesis …

Precision therapy for RET-altered cancers with RET inhibitors

KZ Thein, V Velcheti, BHM Mooers, J Wu, V Subbiah - Trends in cancer, 2021 - cell.com
Rearranged during transfection (RET) is involved in the physiological development of some
organ systems. Activating RET alterations via either gene fusions or point mutations are …

State-of-the-Art Strategies for Targeting RET-Dependent Cancers

V Subbiah, D Yang, V Velcheti, A Drilon… - Journal of Clinical …, 2020 - ascopubs.org
Activating receptor tyrosine kinase RET (rarranged during transfection) gene alterations
have been identified as oncogenic in multiple malignancies. RET gene rearrangements …

RET revisited: expanding the oncogenic portfolio

LM Mulligan - Nature Reviews Cancer, 2014 - nature.com
The RET receptor tyrosine kinase is crucial for normal development but also contributes to
pathologies that reflect both the loss and the gain of RET function. Activation of RET occurs …

Enteric nervous system development: migration, differentiation, and disease

JI Lake, RO Heuckeroth - American Journal of Physiology …, 2013 - journals.physiology.org
The enteric nervous system (ENS) provides the intrinsic innervation of the bowel and is the
most neurochemically diverse branch of the peripheral nervous system, consisting of two …

RET tyrosine kinase signaling in development and cancer

E Arighi, MG Borrello, H Sariola - Cytokine & growth factor reviews, 2005 - Elsevier
The variety of diseases caused by mutations in RET receptor tyrosine kinase provides a
classic example of phenotypic heterogeneity. Gain-of-function mutations of RET are …

RET signaling pathway and RET inhibitors in human cancer

AT Regua, M Najjar, HW Lo - Frontiers in Oncology, 2022 - frontiersin.org
Rearranged during transfection (RET) receptor tyrosine kinase was first identified over thirty
years ago as a novel transforming gene. Since its discovery and subsequent pathway …

The interplay between Src family kinases and receptor tyrosine kinases

PA Bromann, H Korkaya, SA Courtneidge - Oncogene, 2004 - nature.com
Src family tyrosine kinases (SFKs) are involved in a diverse array of physiological
processes, as highlighted in this review. An overview of how SFKs interact with, and …

RET as a Diagnostic and Therapeutic Target in Sporadic and Hereditary Endocrine Tumors

JWB de Groot, TP Links, JTM Plukker… - Endocrine …, 2006 - academic.oup.com
The RET gene encodes a receptor tyrosine kinase that is expressed in neural crest-derived
cell lineages. The RET receptor plays a crucial role in regulating cell proliferation, migration …

The RET/PTC-RAS-BRAF linear signaling cascade mediates the motile and mitogenic phenotype of thyroid cancer cells

RM Melillo, MD Castellone, V Guarino… - The Journal of …, 2005 - Am Soc Clin Investig
In papillary thyroid carcinomas (PTCs), rearrangements of the RET receptor (RET/PTC) and
activating mutations in the BRAF or RAS oncogenes are mutually exclusive. Here we show …